The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

The Swiss aseptic fill-finish manufacturing specialist Baccinex has become the latest in a string of acquisitions by the ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has ...

The promising trial results put icotrokinra on track to fulfill its potential as a best in class oral therapeutic for the chronic skin condition.

By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...

Muvalaplin significantly lowered lipoprotein(a) levels, reducing the risk of cardiovascular events in high-risk adults.

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of ...

The financing round will fund the improvement of the company’s technology platform for the discovery and development of innovative radionuclide drug conjugates.

By working together, Genesis and NVIDIA aim to not only speed up discovery but also to make AI-driven design more accessible for new drug classes. Genesis hopes this joint effort will strengthen its ...

High-level results from an ongoing clinical trial make Astrazeneca’s combination treatment the first to show benefit in a subtype of prostate cancer. AstraZeneca has reported positive results from the ...